162 related articles for article (PubMed ID: 37926766)
1. The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma?
Hu S; Duan H; Lu Y; Huang S
Discov Oncol; 2023 Nov; 14(1):199. PubMed ID: 37926766
[TBL] [Abstract][Full Text] [Related]
2. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
Liu S; Wang S; Wang Z
BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
[TBL] [Abstract][Full Text] [Related]
3. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
[TBL] [Abstract][Full Text] [Related]
5. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
6. Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
Javed M; Bukhari RS; Rasool R; Alhomrani M; Alghamdi SA; Habeeballah H; Ramzan F; Baothman BK; Kashif M; Almaghrabi S; Izmirly AM; Khalid SY
Am J Cancer Res; 2023; 13(5):1826-1844. PubMed ID: 37293145
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation.
Yu W; He X; Zhang C; Huangfu H
Am J Cancer Res; 2023; 13(11):5513-5530. PubMed ID: 38058845
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
Hu R; Lu M; She L
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB.
Li M; Nurzat Y; Huang H; Min P; Zhang X
Front Genet; 2023; 14():1028044. PubMed ID: 36816017
[No Abstract] [Full Text] [Related]
10. Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration.
Wu H; Wang H; Chen Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2793-2804. PubMed ID: 35780251
[TBL] [Abstract][Full Text] [Related]
11. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients.
Sun Y; Zhang Q; Yao L; Wang S; Zhang Z
Transl Cancer Res; 2020 Oct; 9(10):5882-5892. PubMed ID: 35117201
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Nerve-Cancer Cross-Talk-Related Prognostic Gene Model in Head and Neck Squamous Cell Carcinoma.
Li J; Xu Y; Peng G; Zhu K; Wu Z; Shi L; Wu G
Front Oncol; 2021; 11():788671. PubMed ID: 34912722
[TBL] [Abstract][Full Text] [Related]
15. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
Gong X; Ren F
Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD247 in patients with head and neck squamous cell carcinoma: bioinformatic analysis of TCGA database.
Lin P; Hu XL; Hu YY; Liu MY; Wang QY; Ding Y; Ye JC
Ann Transl Med; 2022 Sep; 10(17):923. PubMed ID: 36172089
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ferroptosis driver gene signature in head and neck squamous cell carcinoma (HNSC).
Shaikh K; Iqbal Y; Abdel-Maksoud MA; Murad A; Badar N; Alarjani KM; Siddiqui K; Chandio K; Almanaa TN; Jamil M; Ali M; Jabeen N; Hussein AM
Am J Transl Res; 2023; 15(7):4829-4850. PubMed ID: 37560204
[TBL] [Abstract][Full Text] [Related]
18. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
19. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y
Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491
[TBL] [Abstract][Full Text] [Related]
20. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
